|
TMEM165 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.204480E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.361300E-03 |
| Normal-vs-Stage2 |
6.17579999999673E-05 |
| Normal-vs-Stage3 |
2.014600E-04 |
| Normal-vs-Stage4 |
4.2388999999976E-05 |
| Stage1-vs-Stage2 |
4.273500E-02 |
| Stage1-vs-Stage3 |
1.467590E-01 |
| Stage1-vs-Stage4 |
3.108100E-02 |
| Stage2-vs-Stage3 |
3.538000E-01 |
| Stage2-vs-Stage4 |
9.373000E-01 |
| Stage3-vs-Stage4 |
3.067400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.248600E-04 |
| Normal-vs-AfricanAmerican |
2.302500E-02 |
| Normal-vs-Asian |
3.232900E-04 |
| Caucasian-vs-AfricanAmerican |
8.936000E-01 |
| Caucasian-vs-Asian |
2.286400E-01 |
| AfricanAmerican-vs-Asian |
4.747800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.355800E-03 |
| Normal-vs-Female |
8.38069999999913E-05 |
| Male-vs-Female |
7.452200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.402000E-03 |
| Normal-vs-Age(41-60Yrs) |
2.34359999999878E-05 |
| Normal-vs-Age(61-80Yrs) |
2.44949999999022E-05 |
| Normal-vs-Age(81-100Yrs) |
2.425400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.370500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.866270E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.789800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.176400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.163600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.094150E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.403200E-01 |
| Classical-VS-Follicular |
4.637900E-02 |
| Classical-VS-Other |
7.861200E-01 |
| Classical-VS-Normal |
1.480700E-03 |
| Tall-VS-Follicular |
9.093200E-01 |
| Tall-VS-Other |
4.385000E-01 |
| Tall-VS-Normal |
2.580800E-03 |
| Follicular-VS-Other |
3.946000E-01 |
| Follicular-VS-Normal |
1.154190E-04 |
| Other-VS-Normal |
3.646800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.31619999999E-06 |
| Normal-vs-N1 |
6.514400E-02 |
| N0-vs-N1 |
2.403800E-02 |
|
|
